Document is current

Any future updates will be listed below

1151 Antibody-drug conjugates targeting CLDN18.2 for the treatment of solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.1151

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark